Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference56 articles.
1. Clinical presentation;Poli,2006
2. Hidradenitis suppurativa,2006
3. Current understanding and management of hidradenitis suppurativa;Krbec;J Am Acad Nurse Pract,2007
4. Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3;Gao;J Invest Dermatol,2006
5. The clinical genetics of hidradenitis suppurativa revisited;Von Der Werth;Br J Dermatol,2000
Cited by 366 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Report of successful treatment of follicular occlusion triad with adalimumab and research progress on biologic therapy for follicular occlusion triad;Journal of Dermatological Treatment;2024-09-09
2. Assessing the Role of Adalimumab in Treating Hidradenitis Suppurativa: Findings from a Retrospective Study at a Reference Center;Clinics and Practice;2024-08-27
3. Hidradenitis Suppurativa: New Targets and Emerging Treatments;American Journal of Clinical Dermatology;2024-07-26
4. A Novel Whole Tissue Explant Model of Hidradenitis Suppurativa;2024-07-23
5. Comorbidities, Clinical Presentation, Subtypes, and Treatment of HS Patients in Lithuania;Journal of Clinical Medicine;2024-07-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3